MXPA02011780A - Producto de combinacion que incluye melagatran y un inhibidor de factor xa. - Google Patents
Producto de combinacion que incluye melagatran y un inhibidor de factor xa.Info
- Publication number
- MXPA02011780A MXPA02011780A MXPA02011780A MXPA02011780A MXPA02011780A MX PA02011780 A MXPA02011780 A MX PA02011780A MX PA02011780 A MXPA02011780 A MX PA02011780A MX PA02011780 A MXPA02011780 A MX PA02011780A MX PA02011780 A MXPA02011780 A MX PA02011780A
- Authority
- MX
- Mexico
- Prior art keywords
- combination product
- melagatran
- inhibitor
- factor
- pharmaceutically
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Liquid Crystal Substances (AREA)
- Hydrogenated Pyridines (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Iron Core Of Rotating Electric Machines (AREA)
Abstract
Se provee un producto de combinacion que comprende: (A) melagatran o un derivado del mismo farmaceuticamente aceptable; y (B) un inhibidor de Factor Xa o un derivado del mismo farmaceuticamente aceptable, en el que cada uno de los componentes (A) y (B) esta formulado en combinacion con un coadyuvante, diluyente o excipiente farmaceuticamente aceptable, asi como el uso de dicho producto de combinacion en el tratamiento de una condicion en la que esta indicada la terapia anticoagulante.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0014136.6A GB0014136D0 (en) | 2000-06-10 | 2000-06-10 | Combination therapy |
PCT/SE2001/001288 WO2001095931A1 (en) | 2000-06-10 | 2001-06-06 | A COMBINATION PRODUCT COMPRISING MELAGATRAN AND A FACTOR Xa INHIBITOR |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA02011780A true MXPA02011780A (es) | 2003-04-10 |
Family
ID=9893354
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA02011780A MXPA02011780A (es) | 2000-06-10 | 2001-06-06 | Producto de combinacion que incluye melagatran y un inhibidor de factor xa. |
Country Status (22)
Country | Link |
---|---|
US (1) | US20030158120A1 (es) |
EP (1) | EP1294394B1 (es) |
JP (1) | JP2004503508A (es) |
KR (1) | KR20030007939A (es) |
CN (1) | CN1431912A (es) |
AT (1) | ATE322908T1 (es) |
AU (2) | AU2001264494B2 (es) |
BR (1) | BR0111545A (es) |
CA (1) | CA2410100A1 (es) |
CY (1) | CY1105068T1 (es) |
DE (1) | DE60118732T2 (es) |
DK (1) | DK1294394T3 (es) |
ES (1) | ES2260225T3 (es) |
GB (1) | GB0014136D0 (es) |
HK (1) | HK1052463B (es) |
IL (1) | IL152897A0 (es) |
MX (1) | MXPA02011780A (es) |
NO (1) | NO20025909L (es) |
NZ (1) | NZ522866A (es) |
PT (1) | PT1294394E (es) |
WO (1) | WO2001095931A1 (es) |
ZA (1) | ZA200209487B (es) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE0103590D0 (sv) | 2001-10-26 | 2001-10-26 | Astrazeneca Ab | New Combination |
GB0306615D0 (en) * | 2003-03-22 | 2003-04-30 | Astrazeneca Ab | New use |
WO2007008145A1 (en) * | 2005-07-08 | 2007-01-18 | Astrazeneca Ab | Heterocyclic sulfonamide derivatives as inhibitors of factor xa |
CA2657269A1 (en) * | 2006-07-17 | 2008-01-24 | Boehringer Ingelheim International Gmbh | New indications for direct thrombin inhibitors |
US8790924B2 (en) | 2006-10-19 | 2014-07-29 | Duke University | Reversible platelet inhibition |
CA2825252C (en) | 2011-01-25 | 2018-10-16 | Universite Catholique De Louvain | Compositions of an antithrombin activator and a thrombin inhibitor for use in cell transplantation |
US9687529B2 (en) | 2011-05-05 | 2017-06-27 | Duke University | Method of controlling coagulation |
JP6034406B2 (ja) * | 2012-01-25 | 2016-11-30 | ユニヴェルシテ カソリック ド ルーヴァンUniversite Catholique De Louvain | 細胞移植のための組成物および方法 |
US20160129047A1 (en) | 2013-07-05 | 2016-05-12 | Université Catholique de Louvain | Conditioned medium from human adult liver stem cells and its use in the treatment of liver disorders |
EP2843416A1 (de) * | 2013-09-02 | 2015-03-04 | Siemens Healthcare Diagnostics Products GmbH | Kontroll- und Kalibratormaterial für die Bestimmung von direkten Antikoagulanzien |
WO2016176426A1 (en) | 2015-04-28 | 2016-11-03 | Duke University | Thrombus imaging aptamers and methods of using same |
JP2019528739A (ja) | 2016-09-16 | 2019-10-17 | デューク ユニバーシティ | フォン・ビルブラント因子(vwf)標的薬剤およびそれを用いる方法 |
US11654036B2 (en) | 2020-05-26 | 2023-05-23 | Elixir Medical Corporation | Anticoagulant compounds and methods and devices for their use |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9601556D0 (sv) * | 1996-04-24 | 1996-04-24 | Astra Ab | New pharmaceutical formulation of a thrombin inhibitor for parenteral use |
-
2000
- 2000-06-10 GB GBGB0014136.6A patent/GB0014136D0/en not_active Ceased
-
2001
- 2001-06-06 WO PCT/SE2001/001288 patent/WO2001095931A1/en active IP Right Grant
- 2001-06-06 CA CA002410100A patent/CA2410100A1/en not_active Abandoned
- 2001-06-06 AU AU2001264494A patent/AU2001264494B2/en not_active Ceased
- 2001-06-06 MX MXPA02011780A patent/MXPA02011780A/es active IP Right Grant
- 2001-06-06 DE DE60118732T patent/DE60118732T2/de not_active Expired - Fee Related
- 2001-06-06 ES ES01938923T patent/ES2260225T3/es not_active Expired - Lifetime
- 2001-06-06 EP EP01938923A patent/EP1294394B1/en not_active Expired - Lifetime
- 2001-06-06 PT PT01938923T patent/PT1294394E/pt unknown
- 2001-06-06 IL IL15289701A patent/IL152897A0/xx unknown
- 2001-06-06 US US10/297,537 patent/US20030158120A1/en not_active Abandoned
- 2001-06-06 CN CN01810227A patent/CN1431912A/zh active Pending
- 2001-06-06 NZ NZ522866A patent/NZ522866A/en unknown
- 2001-06-06 BR BR0111545-6A patent/BR0111545A/pt not_active IP Right Cessation
- 2001-06-06 JP JP2002510108A patent/JP2004503508A/ja active Pending
- 2001-06-06 AT AT01938923T patent/ATE322908T1/de not_active IP Right Cessation
- 2001-06-06 KR KR1020027016819A patent/KR20030007939A/ko not_active Application Discontinuation
- 2001-06-06 AU AU6449401A patent/AU6449401A/xx active Pending
- 2001-06-06 DK DK01938923T patent/DK1294394T3/da active
-
2002
- 2002-11-21 ZA ZA200209487A patent/ZA200209487B/en unknown
- 2002-12-09 NO NO20025909A patent/NO20025909L/no not_active Application Discontinuation
-
2003
- 2003-07-03 HK HK03104744.8A patent/HK1052463B/zh not_active IP Right Cessation
-
2006
- 2006-07-07 CY CY20061100937T patent/CY1105068T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
ES2260225T3 (es) | 2006-11-01 |
PT1294394E (pt) | 2006-07-31 |
EP1294394B1 (en) | 2006-04-12 |
AU6449401A (en) | 2001-12-24 |
BR0111545A (pt) | 2003-07-01 |
CA2410100A1 (en) | 2001-12-20 |
DE60118732D1 (de) | 2006-05-24 |
DE60118732T2 (de) | 2006-10-05 |
GB0014136D0 (en) | 2000-08-02 |
DK1294394T3 (da) | 2006-07-10 |
ZA200209487B (en) | 2004-02-23 |
WO2001095931A1 (en) | 2001-12-20 |
HK1052463B (zh) | 2006-10-13 |
CN1431912A (zh) | 2003-07-23 |
JP2004503508A (ja) | 2004-02-05 |
CY1105068T1 (el) | 2010-03-03 |
NO20025909D0 (no) | 2002-12-09 |
EP1294394A1 (en) | 2003-03-26 |
KR20030007939A (ko) | 2003-01-23 |
IL152897A0 (en) | 2003-06-24 |
NO20025909L (no) | 2003-02-07 |
US20030158120A1 (en) | 2003-08-21 |
NZ522866A (en) | 2004-09-24 |
AU2001264494B2 (en) | 2006-01-05 |
ATE322908T1 (de) | 2006-04-15 |
HK1052463A1 (en) | 2003-09-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1105068T1 (el) | ΈΝΑ ΠΡΟΪΟΝ ΣΥΝΔΥΑΣΜΟΥ ΠΟΥ ΠEPΙΛΑΜΒΑΝΕΙ ΜΕΛΑΓΑΤΡΑΝΗ ΚΑΙ ΕΝΑΝ ΑΝΑΣΤΟΛΕΑ ΠΑΡΑΓΟΝΤΑ ΓΙΑ Xa | |
TW200505434A (en) | Therapeutic treatment | |
MXPA03007140A (es) | Derivados de carbolina. | |
AU2001266575A1 (en) | Chemical compounds | |
DE60216233D1 (en) | Carbolinderivate | |
MXPA02012076A (es) | Compuestos quimicos. | |
DE60205899D1 (en) | 1-biaryl-1,8-naphthyridin-4-one als phosphodieseterase-inhibitoren | |
MXPA03002911A (es) | Compuestos quimicos. | |
CY1107343T1 (el) | ΕΝΑ ΠΡΟΪΟΝ ΣΥΝΔΥΑΣΜΟΥ ΠΟΥ ΠEPΙΛΑΜΒΑΝΕΙ ΜΕΛΑΓΑΤΡΑΝΗ ΚΑΙ ΕΝΑΝ ΑΝΑΣΤΟΛΕΑ ΠΑΡΑΓΟΝΤΑ VIIa | |
WO2002070469A3 (en) | Selective pde3b inhibitors and use of the same in therapy | |
GB0018951D0 (en) | Novel compounds | |
PL377176A1 (pl) | N-Sulfonylo-4-metylenoamino-3-hydroksy-2-pirydony | |
GB0027705D0 (en) | Novel compounds | |
MXPA02012472A (es) | Compuestos quimicos. | |
MXPA04003771A (es) | Un producto de combinacion que comprende melagatran y dexametasona. | |
ATE342907T1 (de) | Tumorhemmende lanthanverbindungen | |
WO2003033523A3 (en) | Cytotoxic compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |